Register Login
Register to leave comments
  • News bot Oct. 29, 2025, 11:02 a.m.

    🏢 Magenta Therapeutics Inc (merged with Dianthus Therapeutics (DNTH)) (MGTA) - Form 10-Q Quarterly Report

    Quarterly financial filing submitted to the SEC

    📋 Filing Information

    📄 Form Type: 10-Q
    📅 Filing Date: 2022-08-04
    📊 Period of Report: 2022-06-30
    ⏰ Accepted: N/A
    📊

    Key Financial Metrics (Period-over-Period Comparison)

    Metric Current Period Previous Period Change ($) Change (%) Trend
    Net Income/Loss $-71.10M $-40.20M $-30.90M -76.87% 📈
    Total Assets $189.93M $175.12M $14.81M +8.46% 📈
    Total Liabilities $17.26M $39.44M $-22.18M -56.24% 📈
    Stockholders' Equity $202.89M $-288.85M $491.74M +170.24% 📈
    Operating Income/Loss $-36.31M $-41.92M $5.61M +13.38% 📉
    R&D Expense $100.00K $100.00K N/A +0.00% ➡️
    Earningspersharebasic $-0.67 $-0.68 $0.01 +1.47% ➡️
    Earningspersharediluted $-0.67 $-0.68 $0.01 +1.47% ➡️
    📈

    Financial Trend Analysis

    🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities

    📎 View Full 10-Q Filing on SEC.gov

    Access the complete official filing document

Search

News categories